Cardiovascular effects of low versus high-dose beta-carotene in a rat model

Evelin Csepanyi, Attila Czompa, David Haines, I. Lekli, Edina Bakondi, G. Balla, A. Tósaki, I. Bak

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

β-carotene (BC), a lipid-soluble tetraterpene precursor to vitamin A, widely distributed in plants, including many used in human diet, has well-known health-enhancing properties, including reducing risk of and treatment for certain diseases. Nevertheless, BC may also act to promote disease through the activity of BC derivatives that form in the presence of external toxicants such as cigarette smoke and endogenously-produced reactive oxygen species. The present investigation evaluates the dose-dependent cardioprotective and possibly harmful properties of BC in a rat model. Adult male rats were gavage-fed BC for 4 weeks, at dosages of either 0, 30 or 150 mg/kg/day. Then, hearts excised from the animals were mounted in a "working heart" apparatus and subjected to 30 min of global ischemia, followed by 120 min of reperfusion. A panel of cardiac functional evaluations was conducted on each heart. Infarct size and total antioxidant capacity of the myocardium were assessed. Heart tissue content of heme oxygenase-1 (HO-1) by Western blot analysis; and potential direct cytotoxic effects of BC by MTT assay were evaluated. Hearts taken from rats receiving 30 mg/kg/day BC exhibited significantly improved heart function at lower reperfusion times, but lost this protection at higher BC dosage and longer reperfusion times. Myocardial HO-1 content was significantly elevated dose-responsively to both BC dosage. Finally, in vitro evaluation of BC on H9c2 cells showed that the agent significantly improved vitality of these cells in a dose range of 2.5-10 μM. Although data presented here do not allow for a comprehensive mechanistic explanation for reduced cardioprotection at high dose BC, it is speculated that since Fe2+ produced as a metabolite of HO-1 activity, may determine whether BC acts as an antioxidant or prooxidant agent, the strong induction of this enzyme in response to ischemia/reperfusion-induced oxidative stress may account for the high-dose BC loss of cardioprotection.

Original languageEnglish
Pages (from-to)148-156
Number of pages9
JournalPharmacological Research
Volume100
DOIs
Publication statusPublished - Oct 27 2015

Fingerprint

beta Carotene
Heme Oxygenase-1
Reperfusion
Ischemia
Antioxidants
Enzyme Induction
Carotenoids
Vitamin A
Smoke
Tobacco Products
Reactive Oxygen Species
Myocardium
Oxidative Stress
Western Blotting
Diet
Lipids
Health

Keywords

  • Beta-carotene
  • Heart
  • Heme-oxygenase-1
  • Ischemia/reperfusion

ASJC Scopus subject areas

  • Pharmacology

Cite this

Cardiovascular effects of low versus high-dose beta-carotene in a rat model. / Csepanyi, Evelin; Czompa, Attila; Haines, David; Lekli, I.; Bakondi, Edina; Balla, G.; Tósaki, A.; Bak, I.

In: Pharmacological Research, Vol. 100, 27.10.2015, p. 148-156.

Research output: Contribution to journalArticle

Csepanyi, Evelin ; Czompa, Attila ; Haines, David ; Lekli, I. ; Bakondi, Edina ; Balla, G. ; Tósaki, A. ; Bak, I. / Cardiovascular effects of low versus high-dose beta-carotene in a rat model. In: Pharmacological Research. 2015 ; Vol. 100. pp. 148-156.
@article{099b8783b9924a1e84075457043ec741,
title = "Cardiovascular effects of low versus high-dose beta-carotene in a rat model",
abstract = "β-carotene (BC), a lipid-soluble tetraterpene precursor to vitamin A, widely distributed in plants, including many used in human diet, has well-known health-enhancing properties, including reducing risk of and treatment for certain diseases. Nevertheless, BC may also act to promote disease through the activity of BC derivatives that form in the presence of external toxicants such as cigarette smoke and endogenously-produced reactive oxygen species. The present investigation evaluates the dose-dependent cardioprotective and possibly harmful properties of BC in a rat model. Adult male rats were gavage-fed BC for 4 weeks, at dosages of either 0, 30 or 150 mg/kg/day. Then, hearts excised from the animals were mounted in a {"}working heart{"} apparatus and subjected to 30 min of global ischemia, followed by 120 min of reperfusion. A panel of cardiac functional evaluations was conducted on each heart. Infarct size and total antioxidant capacity of the myocardium were assessed. Heart tissue content of heme oxygenase-1 (HO-1) by Western blot analysis; and potential direct cytotoxic effects of BC by MTT assay were evaluated. Hearts taken from rats receiving 30 mg/kg/day BC exhibited significantly improved heart function at lower reperfusion times, but lost this protection at higher BC dosage and longer reperfusion times. Myocardial HO-1 content was significantly elevated dose-responsively to both BC dosage. Finally, in vitro evaluation of BC on H9c2 cells showed that the agent significantly improved vitality of these cells in a dose range of 2.5-10 μM. Although data presented here do not allow for a comprehensive mechanistic explanation for reduced cardioprotection at high dose BC, it is speculated that since Fe2+ produced as a metabolite of HO-1 activity, may determine whether BC acts as an antioxidant or prooxidant agent, the strong induction of this enzyme in response to ischemia/reperfusion-induced oxidative stress may account for the high-dose BC loss of cardioprotection.",
keywords = "Beta-carotene, Heart, Heme-oxygenase-1, Ischemia/reperfusion",
author = "Evelin Csepanyi and Attila Czompa and David Haines and I. Lekli and Edina Bakondi and G. Balla and A. T{\'o}saki and I. Bak",
year = "2015",
month = "10",
day = "27",
doi = "10.1016/j.phrs.2015.07.021",
language = "English",
volume = "100",
pages = "148--156",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Cardiovascular effects of low versus high-dose beta-carotene in a rat model

AU - Csepanyi, Evelin

AU - Czompa, Attila

AU - Haines, David

AU - Lekli, I.

AU - Bakondi, Edina

AU - Balla, G.

AU - Tósaki, A.

AU - Bak, I.

PY - 2015/10/27

Y1 - 2015/10/27

N2 - β-carotene (BC), a lipid-soluble tetraterpene precursor to vitamin A, widely distributed in plants, including many used in human diet, has well-known health-enhancing properties, including reducing risk of and treatment for certain diseases. Nevertheless, BC may also act to promote disease through the activity of BC derivatives that form in the presence of external toxicants such as cigarette smoke and endogenously-produced reactive oxygen species. The present investigation evaluates the dose-dependent cardioprotective and possibly harmful properties of BC in a rat model. Adult male rats were gavage-fed BC for 4 weeks, at dosages of either 0, 30 or 150 mg/kg/day. Then, hearts excised from the animals were mounted in a "working heart" apparatus and subjected to 30 min of global ischemia, followed by 120 min of reperfusion. A panel of cardiac functional evaluations was conducted on each heart. Infarct size and total antioxidant capacity of the myocardium were assessed. Heart tissue content of heme oxygenase-1 (HO-1) by Western blot analysis; and potential direct cytotoxic effects of BC by MTT assay were evaluated. Hearts taken from rats receiving 30 mg/kg/day BC exhibited significantly improved heart function at lower reperfusion times, but lost this protection at higher BC dosage and longer reperfusion times. Myocardial HO-1 content was significantly elevated dose-responsively to both BC dosage. Finally, in vitro evaluation of BC on H9c2 cells showed that the agent significantly improved vitality of these cells in a dose range of 2.5-10 μM. Although data presented here do not allow for a comprehensive mechanistic explanation for reduced cardioprotection at high dose BC, it is speculated that since Fe2+ produced as a metabolite of HO-1 activity, may determine whether BC acts as an antioxidant or prooxidant agent, the strong induction of this enzyme in response to ischemia/reperfusion-induced oxidative stress may account for the high-dose BC loss of cardioprotection.

AB - β-carotene (BC), a lipid-soluble tetraterpene precursor to vitamin A, widely distributed in plants, including many used in human diet, has well-known health-enhancing properties, including reducing risk of and treatment for certain diseases. Nevertheless, BC may also act to promote disease through the activity of BC derivatives that form in the presence of external toxicants such as cigarette smoke and endogenously-produced reactive oxygen species. The present investigation evaluates the dose-dependent cardioprotective and possibly harmful properties of BC in a rat model. Adult male rats were gavage-fed BC for 4 weeks, at dosages of either 0, 30 or 150 mg/kg/day. Then, hearts excised from the animals were mounted in a "working heart" apparatus and subjected to 30 min of global ischemia, followed by 120 min of reperfusion. A panel of cardiac functional evaluations was conducted on each heart. Infarct size and total antioxidant capacity of the myocardium were assessed. Heart tissue content of heme oxygenase-1 (HO-1) by Western blot analysis; and potential direct cytotoxic effects of BC by MTT assay were evaluated. Hearts taken from rats receiving 30 mg/kg/day BC exhibited significantly improved heart function at lower reperfusion times, but lost this protection at higher BC dosage and longer reperfusion times. Myocardial HO-1 content was significantly elevated dose-responsively to both BC dosage. Finally, in vitro evaluation of BC on H9c2 cells showed that the agent significantly improved vitality of these cells in a dose range of 2.5-10 μM. Although data presented here do not allow for a comprehensive mechanistic explanation for reduced cardioprotection at high dose BC, it is speculated that since Fe2+ produced as a metabolite of HO-1 activity, may determine whether BC acts as an antioxidant or prooxidant agent, the strong induction of this enzyme in response to ischemia/reperfusion-induced oxidative stress may account for the high-dose BC loss of cardioprotection.

KW - Beta-carotene

KW - Heart

KW - Heme-oxygenase-1

KW - Ischemia/reperfusion

UR - http://www.scopus.com/inward/record.url?scp=84940040945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940040945&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2015.07.021

DO - 10.1016/j.phrs.2015.07.021

M3 - Article

C2 - 26225824

AN - SCOPUS:84940040945

VL - 100

SP - 148

EP - 156

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

ER -